电引导与影像引导左室电极植入在心脏再同步治疗中的双盲随机对照试验方案
本研究为双盲随机对照试验,计划纳入122例心力衰竭伴QRS增宽接受CRT的患者,比较电标测引导与影像引导左室电极植入对6个月LVEF变化的影响。主要终点为6个月随访时二维超声测量的LVEF较基线变化,假设干预组绝对增加12%、对照组8%。
要点
- 电标测引导左室电极植入可能较影像引导更提高LVEF。
- 主要终点为6个月LVEF较基线变化,采用二维超声测量。
- 研究结果为未来更大规模临床结局试验提供依据。
核心结论
- 若电标测引导左室电极植入能额外提高LVEF,将支持开展更大规模的临床结局研究。
研究设计与样本
- 患者盲、评估者盲的随机对照临床试验,计划纳入122例患者。
- 干预组在心脏CT静脉解剖基础上,经冠状静脉窦系统电标测定位最晚左室激动位点放置电极,并术后优化室间起搏延迟。
- 对照组经超声定位最晚机械激动且避开灌注成像所示心肌瘢痕的位置放置电极。
关键数值与推荐
- 主要终点为6个月随访时二维超声测量的LVEF较基线变化。
- 次要终点包括左室收缩末期容积相对百分比减少、全因死亡、心衰住院及6个月临床复合应答终点。
- 临床复合应答定义为存活、未因心衰住院且NYHA功能分级改善或6分钟步行试验增加>10%。
- 假设干预组LVEF绝对增加12%,对照组增加8%。
临床怎么用
- 研究结果尚待报告,暂不能直接指导临床决策。
局限性
- 原文未报告研究结果,仅为研究方案。
- 原文未报告样本量计算的具体依据及随访细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cardiac resynchronization therapy (CRT) is an established treatment in patients with heart failure and prolonged QRS duration where a biventricular pacemaker is implanted to achieve faster activation and more synchronous contraction of the left ventricle (LV). Despite the convincing effect of CRT, 30-40% of patients do not respond. Among the most important correctable causes of non-response to CRT is non-optimal LV lead position. METHODS: We will enroll 122 patients in this patient-blinded and assessor-blinded, randomized, clinical trial aiming to investigate if implanting the LV lead guided by electrical mapping towards the latest LV activation as compared with imaging-guided implantation, causes an excess increase in left ventricular (LV) ejection fraction (LVEF). The patients are randomly assigned to either the intervention group: preceded by cardiac computed tomography of the cardiac venous anatomy, the LV lead is placed according to the latest LV activation in the coronary sinus (CS) branches identified by systematic electrical mapping of the CS at implantation and post-implant optimization of the interventricular pacing delay; or patients are assigned to the control group: placement of the LV lead guided by cardiac imaging. The LV lead is targeted towards the latest mechanical LV activation as identified by echocardiography and outside myocardial scar as identified by myocardial perfusion (MP) imaging. The primary endpoint is change in LVEF at 6-month follow up (6MFU) as compared with baseline measured by two-dimensional echocardiography. Secondary endpoints include relative percentage reduction in LV end-systolic volume, all-cause mortality, hospitalization for heart failure, and a clinical combined endpoint of response to CRT at 6MFU defined as the patient being alive, not hospitalized for heart failure, and experiencing improvement in NYHA functional class or/and > 10% increase in 6-minute walk test. DISCUSSION: We assume an absolute increase in LVEF of 12% in the intervention group versus 8% in the control group. If an excess increase in LVEF can be achieved by LV lead implantation guided by electrical mapping, this study supports the conduct of larger trials investigating the impact of this strategy for LV-lead implantation on clinical outcomes in patients treated with CRT. TRIAL REGISTRATION: ClinicalTrials.gov, NCT02346097 . Registered on 12 January 2015. Patients were enrolled between 16 February 2015 and 13 December 2017.
引用
- Stephansen C, Sommer A, Kronborg MB, et al. Electrically guided versus imaging-guided implant of the left ventricular lead in cardiac resynchronization therapy: a study protocol for a double-blinded randomized controlled clinical trial (ElectroCRT). Trials. 2018. PMID: 30382923. doi:10.1186/s13063-018-2930-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。